Gregory L. Summe Purchases 30,000 Shares of Avantor, Inc. (NYSE:AVTR) Stock

Avantor, Inc. (NYSE:AVTR) Director Gregory L. Summe acquired 30,000 shares of the stock in a transaction dated Friday, May 23rd. The shares were bought at an average cost of $12.50 per share, with a total value of $375,000.00. Following the completion of the purchase, the director now directly owns 100,000 shares in the company, valued at approximately $1,250,000. This trade represents a 42.86% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Avantor Stock Down 1.0%

NYSE AVTR opened at $13.03 on Thursday. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a fifty-two week low of $11.82 and a fifty-two week high of $28.00. The business has a 50 day moving average price of $14.22 and a two-hundred day moving average price of $18.08. The stock has a market cap of $8.88 billion, a PE ratio of 12.52, a P/E/G ratio of 1.55 and a beta of 1.09.

Avantor (NYSE:AVTR) last announced its earnings results on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a net margin of 10.49% and a return on equity of 12.17%. The business’s quarterly revenue was down 5.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.22 earnings per share. As a group, sell-side analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Institutional Investors Weigh In On Avantor

A number of institutional investors have recently modified their holdings of the stock. Nisa Investment Advisors LLC increased its position in Avantor by 917.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 20,700 shares of the company’s stock worth $436,000 after buying an additional 18,665 shares during the period. Blue Trust Inc. lifted its holdings in Avantor by 6.9% in the fourth quarter. Blue Trust Inc. now owns 8,069 shares of the company’s stock worth $170,000 after purchasing an additional 522 shares during the period. Pacer Advisors Inc. grew its position in Avantor by 0.5% in the 4th quarter. Pacer Advisors Inc. now owns 99,825 shares of the company’s stock valued at $2,103,000 after buying an additional 542 shares in the last quarter. CKW Financial Group grew its position in Avantor by 116.7% in the 4th quarter. CKW Financial Group now owns 5,200 shares of the company’s stock valued at $110,000 after buying an additional 2,800 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its stake in Avantor by 38.1% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 119,063 shares of the company’s stock valued at $2,509,000 after buying an additional 32,838 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on AVTR. Royal Bank of Canada reduced their target price on Avantor from $24.00 to $20.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. TD Cowen lowered Avantor from a “buy” rating to a “hold” rating and set a $15.50 price objective on the stock. in a research note on Monday, April 28th. The Goldman Sachs Group downgraded shares of Avantor from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $23.00 to $14.00 in a research report on Tuesday, April 29th. Barclays cut their price target on shares of Avantor from $18.00 to $15.00 and set an “overweight” rating on the stock in a report on Monday, April 28th. Finally, Wells Fargo & Company decreased their price objective on shares of Avantor from $25.00 to $22.00 and set an “overweight” rating for the company in a research note on Thursday, April 17th. Seven equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Avantor presently has a consensus rating of “Hold” and a consensus target price of $18.88.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.